fpl-52694 has been researched along with cimetidine in 9 studies
| Studies (fpl-52694) | Trials (fpl-52694) | Recent Studies (post-2010) (fpl-52694) | Studies (cimetidine) | Trials (cimetidine) | Recent Studies (post-2010) (cimetidine) |
|---|---|---|---|---|---|
| 25 | 1 | 1 | 9,473 | 1,687 | 377 |
| Protein | Taxonomy | fpl-52694 (IC50) | cimetidine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.59 | |
| Solute carrier family 22 member 2 | Mus musculus (house mouse) | 8 | |
| Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 0.82 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.1742 | |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | 1.02 | |
| Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 0.82 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 3.0333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Nobuhara, Y; Ohtsuki, H; Okabe, S; Takeuchi, K | 1 |
| Ohtsuki, H; Okabe, S; Takeuchi, K | 1 |
| Canfield, SP; Curwain, BP | 3 |
| Ishihara, Y; Kunimi, H; Okabe, S; Takeuchi, K | 1 |
| Smith, JA | 1 |
| Asada, Y; Ishihara, Y; Kato, S; Takeuchi, K; Yasuhiro, T | 1 |
9 other study(ies) available for fpl-52694 and cimetidine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Mechanisms of irritative activity of compound 48/80 on rat gastric mucosa.
Topics: Animals; Chromones; Cimetidine; Electric Conductivity; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Male; Membrane Potentials; Methysergide; p-Methoxy-N-methylphenethylamine; Rats; Serotonin; Tripelennamine | 1986 |
Pathogenesis of compound 48/80-induced gastric lesions in rats.
Topics: Animals; Blood Pressure; Chromones; Cimetidine; Cyproheptadine; Drug Interactions; Gastric Mucosa; Histamine; Male; Mast Cells; Methysergide; p-Methoxy-N-methylphenethylamine; Rats; Serotonin; Stomach Diseases; Tripelennamine | 1986 |
Gastric juice electrolyte secretion in conscious dogs with gastric fistulae and its modification by FPL 52694, a mast cell stabilizing agent.
Topics: Animals; Chromones; Cimetidine; Dogs; Electrolytes; Gastric Fistula; Gastric Juice; Histamine; Insulin; Male; Mast Cells; Pentagastrin | 1983 |
Effects of FPL-52694, a new mast cell stabilizer, on gastric secretion and various acute gastric lesions in rats.
Topics: Animals; Aspirin; Chromones; Cimetidine; Gastric Juice; Histamine; Humans; Male; Mast Cells; Pylorus; Rats; Rats, Inbred Strains; Reserpine; Stomach Ulcer; Stress, Psychological | 1984 |
Inhibition of gastric acid secretion in the conscious dog by the mast-cell stabilizing agent, FPL 52694.
Topics: Animals; Chromones; Cimetidine; Depression, Chemical; Dogs; Drug Interactions; Gastric Acid; Gastric Fistula; Histamine; Infusions, Parenteral; Male; Pentagastrin | 1983 |
Inhibition of gastric acid secretion in conscious dog with fistula following intragastric administration of FPL 52694.
Topics: Animals; Chromones; Cimetidine; Dogs; Gastric Fistula; Gastric Juice; Histamine; Male; Pentagastrin | 1983 |
The effect of atropine, cimetidine and FPL 52694 on duodenal ulcers in mice.
Topics: Animals; Anti-Ulcer Agents; Atropine; Chromones; Cimetidine; Cysteamine; Duodenal Ulcer; Female; Guanidines; Mice; Rats; Rats, Inbred Strains; Species Specificity | 1983 |
Stimulation of acid secretion in rat stomach following exposure to taurocholate in the presence of the nitric oxide synthase inhibitor.
Topics: Animals; Cell Count; Chromones; Cimetidine; Enzyme Inhibitors; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastrointestinal Agents; Histamine H2 Antagonists; Histamine Release; Hydrogen-Ion Concentration; Male; Mast Cells; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Taurocholic Acid | 1996 |